22.11.2017 16:00:00
|
Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference
BOULDER, Colo., Nov. 22, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Piper Jaffray Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Piper Jaffray Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Wednesday, November 29, 2017 |
Time: | 9:00 a.m. Eastern Time |
Webcast: | https://event.webcasts.com/starthere.jsp?ei=1171462&tp_key=889917fd39 |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-piper-jaffray-healthcare-conference-300556111.html
SOURCE Array BioPharma Inc.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Array BioPharma Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |